Target identification in drug discovery

Identifying the biological origin of a disease, and the potential targets for intervention, is the first step in the discovery of a medicine. More an art than a science, target identification is grounded in a number of different approaches and technologies.
We are building next generation sequencing solutions which give us wider access to genomic data and biomarkers allowing us to translate this data into clinical trials.